Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Carbohydrate Restriction in Type 1 Diabetes: A Realistic Therapy for Improved Glycaemic Control and Athletic Performance?

Scott SN, Anderson L, Morton JP, Wagenmakers AJM, Riddell MC.

Nutrients. 2019 May 7;11(5). pii: E1022. doi: 10.3390/nu11051022. Review.

2.

Neural Circuits Associated with 5-HT1B Receptor Agonist Inhibition of Methamphetamine Seeking in the Conditioned Place Preference Model.

Der-Ghazarian TS, Charmchi D, Noudali SN, Scott SN, Holter MC, Newbern JM, Neisewander JL.

ACS Chem Neurosci. 2019 May 29. doi: 10.1021/acschemneuro.8b00709. [Epub ahead of print]

PMID:
31042352
3.

The repertoire of genetic alterations in salivary duct carcinoma including a novel HNRNPH3-ALK rearrangement.

Dogan S, Ng CKY, Xu B, Kumar R, Wang L, Edelweiss M, Scott SN, Zehir A, Drilon A, Morris LGT, Lee NY, Antonescu CR, Ho AL, Katabi N, Berger MF, Reis-Filho JS.

Hum Pathol. 2019 Apr 1. pii: S0046-8177(19)30049-8. doi: 10.1016/j.humpath.2019.03.004. [Epub ahead of print] Spanish.

PMID:
30946933
4.

Development and Validation of a PACER Prediction Equation for VO2peak in 10- to 15-Year-Old Youth.

Scott SN, Springer CM, Oody JF, McClanahan MS, Wiseman BD, Kybartas TJ, Coe DP.

Pediatr Exerc Sci. 2019 May 1;31(2):223-228. doi: 10.1123/pes.2018-0136. Epub 2019 Jan 3.

PMID:
30606067
5.

A transgenic tool to assess Anopheles mating competitiveness in the field.

Smidler AL, Scott SN, Mameli E, Shaw WR, Catteruccia F.

Parasit Vectors. 2018 Dec 24;11(Suppl 2):651. doi: 10.1186/s13071-018-3218-5.

6.

Addendum: Effects of a 5-HT1B Receptor Agonist on Locomotion and Reinstatement of Cocaine-Conditioned Place Preference after Abstinence from Repeated Injections in Mice.

Der-Ghazarian TS, Call T, Scott SN, Dai K, Brunwasser SJ, Noudali SN, Pentkowski NS, Neisewander JL.

Front Syst Neurosci. 2018 Nov 7;12:48. doi: 10.3389/fnsys.2018.00048. eCollection 2018. No abstract available.

7.

High-Intensity Interval Training Improves Aerobic Capacity Without a Detrimental Decline in Blood Glucose in People With Type 1 Diabetes.

Scott SN, Cocks M, Andrews RC, Narendran P, Purewal TS, Cuthbertson DJ, Wagenmakers AJM, Shepherd SO.

J Clin Endocrinol Metab. 2019 Feb 1;104(2):604-612. doi: 10.1210/jc.2018-01309.

PMID:
30281094
8.

Fasted High-Intensity Interval and Moderate-Intensity Exercise Do Not Lead to Detrimental 24-Hour Blood Glucose Profiles.

Scott SN, Cocks M, Andrews RC, Narendran P, Purewal TS, Cuthbertson DJ, Wagenmakers AJM, Shepherd SO.

J Clin Endocrinol Metab. 2019 Jan 1;104(1):111-117. doi: 10.1210/jc.2018-01308.

PMID:
30252054
9.

Animal Models of the Impact of Social Stress on Cocaine Use Disorders.

Vannan A, Powell GL, Scott SN, Pagni BA, Neisewander JL.

Int Rev Neurobiol. 2018;140:131-169. doi: 10.1016/bs.irn.2018.07.005. Epub 2018 Aug 20. Review.

PMID:
30193703
10.

Effects of a 5-HT1B Receptor Agonist on Locomotion and Reinstatement of Cocaine-Conditioned Place Preference after Abstinence from Repeated Injections in Mice.

Der-Ghazarian TS, Call T, Scott SN, Dai K, Brunwasser SJ, Noudali SN, Pentkowski NS, Neisewander JL.

Front Syst Neurosci. 2017 Oct 10;11:73. doi: 10.3389/fnsys.2017.00073. eCollection 2017. Erratum in: Front Syst Neurosci. 2018 Nov 07;12:48.

11.

The genetic landscape of endometrial clear cell carcinomas.

DeLair DF, Burke KA, Selenica P, Lim RS, Scott SN, Middha S, Mohanty AS, Cheng DT, Berger MF, Soslow RA, Weigelt B.

J Pathol. 2017 Oct;243(2):230-241. doi: 10.1002/path.4947. Epub 2017 Sep 5.

12.

Next-generation sequencing of urine specimens: A novel platform for genomic analysis in patients with non-muscle-invasive urothelial carcinoma treated with bacille Calmette-Guérin.

Scott SN, Ostrovnaya I, Lin CM, Bouvier N, Bochner BH, Iyer G, Solit D, Berger MF, Lin O.

Cancer Cytopathol. 2017 Jun;125(6):416-426. doi: 10.1002/cncy.21847. Epub 2017 Mar 24.

13.

Genomic characterization of response to chemoradiation in urothelial bladder cancer.

Desai NB, Scott SN, Zabor EC, Cha EK, Hreiki J, Sfakianos JP, Ramirez R, Bagrodia A, Rosenberg JE, Bajorin DF, Berger MF, Bochner BH, Zelefsky MJ, Kollmeier MA, Ostrovnaya I, Al-Ahmadie HA, Solit DB, Iyer G.

Cancer. 2016 Dec 1;122(23):3715-3723. doi: 10.1002/cncr.30219. Epub 2016 Aug 1.

14.

The oncocytic subtype is genetically distinct from other pancreatic intraductal papillary mucinous neoplasm subtypes.

Basturk O, Tan M, Bhanot U, Allen P, Adsay V, Scott SN, Shah R, Berger MF, Askan G, Dikoglu E, Jobanputra V, Wrzeszczynski KO, Sigel C, Iacobuzio-Donahue C, Klimstra DS.

Mod Pathol. 2016 Sep;29(9):1058-69. doi: 10.1038/modpathol.2016.98. Epub 2016 Jun 10.

15.

Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancer.

Al-Ahmadie HA, Iyer G, Lee BH, Scott SN, Mehra R, Bagrodia A, Jordan EJ, Gao SP, Ramirez R, Cha EK, Desai NB, Zabor EC, Ostrovnaya I, Gopalan A, Chen YB, Fine SW, Tickoo SK, Gandhi A, Hreiki J, Viale A, Arcila ME, Dalbagni G, Rosenberg JE, Bochner BH, Bajorin DF, Berger MF, Reuter VE, Taylor BS, Solit DB.

Nat Genet. 2016 Apr;48(4):356-8. doi: 10.1038/ng.3503. Epub 2016 Feb 22.

16.

Genomic Biomarkers for the Prediction of Stage and Prognosis of Upper Tract Urothelial Carcinoma.

Bagrodia A, Cha EK, Sfakianos JP, Zabor EC, Bochner BH, Al-Ahmadie HA, Solit DB, Coleman JA, Iyer G, Scott SN, Shah R, Ostrovnaya I, Lee B, Desai NB, Ren Q, Rosenberg JE, Dalbagni G, Bajorin DF, Reuter VE, Berger MF; Collaborators.

J Urol. 2016 Jun;195(6):1684-1689. doi: 10.1016/j.juro.2016.01.006. Epub 2016 Jan 14.

17.

Targeted exome sequencing profiles genetic alterations in leiomyosarcoma.

Agaram NP, Zhang L, LeLoarer F, Silk T, Sung YS, Scott SN, Kuk D, Qin LX, Berger MF, Antonescu CR, Singer S.

Genes Chromosomes Cancer. 2016 Feb;55(2):124-30. doi: 10.1002/gcc.22318. Epub 2015 Nov 6.

18.

Alternative transcription initiation leads to expression of a novel ALK isoform in cancer.

Wiesner T, Lee W, Obenauf AC, Ran L, Murali R, Zhang QF, Wong EW, Hu W, Scott SN, Shah RH, Landa I, Button J, Lailler N, Sboner A, Gao D, Murphy DA, Cao Z, Shukla S, Hollmann TJ, Wang L, Borsu L, Merghoub T, Schwartz GK, Postow MA, Ariyan CE, Fagin JA, Zheng D, Ladanyi M, Busam KJ, Berger MF, Chen Y, Chi P.

Nature. 2015 Oct 15;526(7573):453-7. doi: 10.1038/nature15258. Epub 2015 Oct 7.

19.

Genomic Characterization of Upper Tract Urothelial Carcinoma.

Sfakianos JP, Cha EK, Iyer G, Scott SN, Zabor EC, Shah RH, Ren Q, Bagrodia A, Kim PH, Hakimi AA, Ostrovnaya I, Ramirez R, Hanrahan AJ, Desai NB, Sun A, Pinciroli P, Rosenberg JE, Dalbagni G, Schultz N, Bajorin DF, Reuter VE, Berger MF, Bochner BH, Al-Ahmadie HA, Solit DB, Coleman JA.

Eur Urol. 2015 Dec;68(6):970-7. doi: 10.1016/j.eururo.2015.07.039. Epub 2015 Aug 14.

20.

NF1 Mutations Are Common in Desmoplastic Melanoma.

Wiesner T, Kiuru M, Scott SN, Arcila M, Halpern AC, Hollmann T, Berger MF, Busam KJ.

Am J Surg Pathol. 2015 Oct;39(10):1357-62. doi: 10.1097/PAS.0000000000000451.

21.

Cutaneous squamous and neuroendocrine carcinoma: genetically and immunohistochemically different from Merkel cell carcinoma.

Pulitzer MP, Brannon AR, Berger MF, Louis P, Scott SN, Jungbluth AA, Coit DG, Brownell I, Busam KJ.

Mod Pathol. 2015 Aug;28(8):1023-32. doi: 10.1038/modpathol.2015.60. Epub 2015 May 29.

22.

GNAS and KRAS Mutations Define Separate Progression Pathways in Intraductal Papillary Mucinous Neoplasm-Associated Carcinoma.

Tan MC, Basturk O, Brannon AR, Bhanot U, Scott SN, Bouvier N, LaFemina J, Jarnagin WR, Berger MF, Klimstra D, Allen PJ.

J Am Coll Surg. 2015 May;220(5):845-854.e1. doi: 10.1016/j.jamcollsurg.2014.11.029. Epub 2015 Feb 11.

23.

Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology.

Cheng DT, Mitchell TN, Zehir A, Shah RH, Benayed R, Syed A, Chandramohan R, Liu ZY, Won HH, Scott SN, Brannon AR, O'Reilly C, Sadowska J, Casanova J, Yannes A, Hechtman JF, Yao J, Song W, Ross DS, Oultache A, Dogan S, Borsu L, Hameed M, Nafa K, Arcila ME, Ladanyi M, Berger MF.

J Mol Diagn. 2015 May;17(3):251-64. doi: 10.1016/j.jmoldx.2014.12.006. Epub 2015 Mar 20.

24.

Comprehensive mutation profiling by next-generation sequencing of effusion fluids from patients with high-grade serous ovarian carcinoma.

Shah RH, Scott SN, Brannon AR, Levine DA, Lin O, Berger MF.

Cancer Cytopathol. 2015 May;123(5):289-97. doi: 10.1002/cncy.21522. Epub 2015 Feb 5.

25.

Validity of Physical Activity Monitors for Estimating Energy Expenditure During Wheelchair Propulsion.

Conger SA, Scott SN, Fitzhugh EC, Thompson DL, Bassett DR.

J Phys Act Health. 2015 Nov;12(11):1520-6. doi: 10.1123/jpah.2014-0376. Epub 2015 Jan 30.

PMID:
25635408
26.

Comparative sequencing analysis reveals high genomic concordance between matched primary and metastatic colorectal cancer lesions.

Brannon AR, Vakiani E, Sylvester BE, Scott SN, McDermott G, Shah RH, Kania K, Viale A, Oschwald DM, Vacic V, Emde AK, Cercek A, Yaeger R, Kemeny NE, Saltz LB, Shia J, D'Angelica MI, Weiser MR, Solit DB, Berger MF.

Genome Biol. 2014 Aug 28;15(8):454. doi: 10.1186/s13059-014-0454-7.

27.

Genomic predictors of survival in patients with high-grade urothelial carcinoma of the bladder.

Kim PH, Cha EK, Sfakianos JP, Iyer G, Zabor EC, Scott SN, Ostrovnaya I, Ramirez R, Sun A, Shah R, Yee AM, Reuter VE, Bajorin DF, Rosenberg JE, Schultz N, Berger MF, Al-Ahmadie HA, Solit DB, Bochner BH.

Eur Urol. 2015 Feb;67(2):198-201. doi: 10.1016/j.eururo.2014.06.050. Epub 2014 Aug 1.

28.

Synthetic lethality in ATM-deficient RAD50-mutant tumors underlies outlier response to cancer therapy.

Al-Ahmadie H, Iyer G, Hohl M, Asthana S, Inagaki A, Schultz N, Hanrahan AJ, Scott SN, Brannon AR, McDermott GC, Pirun M, Ostrovnaya I, Kim P, Socci ND, Viale A, Schwartz GK, Reuter V, Bochner BH, Rosenberg JE, Bajorin DF, Berger MF, Petrini JH, Solit DB, Taylor BS.

Cancer Discov. 2014 Sep;4(9):1014-21. doi: 10.1158/2159-8290.CD-14-0380. Epub 2014 Jun 16.

29.

Predicting energy expenditure through hand rim propulsion power output in individuals who use wheelchairs.

Conger SA, Scott SN, Bassett DR Jr.

Br J Sports Med. 2014 Jul;48(13):1048-53. doi: 10.1136/bjsports-2014-093540. Epub 2014 May 13.

PMID:
24825852
30.

Recurrent SMARCA4 mutations in small cell carcinoma of the ovary.

Jelinic P, Mueller JJ, Olvera N, Dao F, Scott SN, Shah R, Gao J, Schultz N, Gonen M, Soslow RA, Berger MF, Levine DA.

Nat Genet. 2014 May;46(5):424-6. doi: 10.1038/ng.2922. Epub 2014 Mar 23.

31.

Tumor genetic analyses of patients with metastatic renal cell carcinoma and extended benefit from mTOR inhibitor therapy.

Voss MH, Hakimi AA, Pham CG, Brannon AR, Chen YB, Cunha LF, Akin O, Liu H, Takeda S, Scott SN, Socci ND, Viale A, Schultz N, Sander C, Reuter VE, Russo P, Cheng EH, Motzer RJ, Berger MF, Hsieh JJ.

Clin Cancer Res. 2014 Apr 1;20(7):1955-64. doi: 10.1158/1078-0432.CCR-13-2345. Epub 2014 Mar 12.

32.

Detecting somatic genetic alterations in tumor specimens by exon capture and massively parallel sequencing.

Won HH, Scott SN, Brannon AR, Shah RH, Berger MF.

J Vis Exp. 2013 Oct 18;(80):e50710. doi: 10.3791/50710.

33.

Phase II trial of MEK inhibitor selumetinib (AZD6244, ARRY-142886) in patients with BRAFV600E/K-mutated melanoma.

Catalanotti F, Solit DB, Pulitzer MP, Berger MF, Scott SN, Iyriboz T, Lacouture ME, Panageas KS, Wolchok JD, Carvajal RD, Schwartz GK, Rosen N, Chapman PB.

Clin Cancer Res. 2013 Apr 15;19(8):2257-64. doi: 10.1158/1078-0432.CCR-12-3476. Epub 2013 Feb 26.

34.

The ability of the PACER to elicit peak exercise response in youth [corrected].

Scott SN, Thompson DL, Coe DP.

Med Sci Sports Exerc. 2013 Jun;45(6):1139-43. doi: 10.1249/MSS.0b013e318281e4a8. Erratum in: Med Sci Sports Exerc. 2013 Sep;45(9):1842.

PMID:
23274606
35.

Genome sequencing identifies a basis for everolimus sensitivity.

Iyer G, Hanrahan AJ, Milowsky MI, Al-Ahmadie H, Scott SN, Janakiraman M, Pirun M, Sander C, Socci ND, Ostrovnaya I, Viale A, Heguy A, Peng L, Chan TA, Bochner B, Bajorin DF, Berger MF, Taylor BS, Solit DB.

Science. 2012 Oct 12;338(6104):221. doi: 10.1126/science.1226344. Epub 2012 Aug 23.

36.

Morphological shifts in island-dwelling birds: the roles of generalist foraging and niche expansion.

Scott SN, Clegg SM, Blomberg SP, Kikkawa J, Owens IP.

Evolution. 2003 Sep;57(9):2147-56.

PMID:
14575334
37.

Influence of biological, behavioural, health service and social risk factors on the trend towards more frequent.

Hanlon P, Walsh D, Whyte BW, Scott SN, Hole D, Lightbody P, Gilhooly ML.

Health Bull (Edinb). 2000 Jul;58(4):342-53.

PMID:
12813816
38.

The effects of epoetin alfa on transfusion requirements in head and neck cancer patients: a prospective, randomized, placebo-controlled study.

Scott SN, Boeve TJ, McCulloch TM, Fitzpatrick KA, Karnell LH.

Laryngoscope. 2002 Jul;112(7 Pt 1):1221-9.

PMID:
12169903
39.

The effects of fluticasone propionate on nasal epithelial potential difference.

Graham SM, Scott SN, Launspach J, Zabner J.

Am J Rhinol. 2002 May-Jun;16(3):145-9.

PMID:
12141771
40.

Deciding how NHS money is spent: a survey of general public and medical views.

Lees A, Scott N, Scott SN, MacDonald S, Campbell C.

Health Expect. 2002 Mar;5(1):47-54.

41.
42.

The link between major risk factors and important categories of admission in an ageing cohort.

Hanlon P, Walsh D, Whyte BW, Scott SN, Lightbody P, Gilhooly ML.

J Public Health Med. 2000 Mar;22(1):81-9.

PMID:
10774909
43.

Brown tumor of the palate in a patient with primary hyperparathyroidism.

Scott SN, Graham SM, Sato Y, Robinson RA.

Ann Otol Rhinol Laryngol. 1999 Jan;108(1):91-4. No abstract available.

PMID:
9930547
44.

Hospital use by an ageing cohort: an investigation into the association between biological, behavioural and social risk markers and subsequent hospital utilization.

Hanlon P, Walsh D, Whyte BW, Scott SN, Lightbody P, Gilhooly ML.

J Public Health Med. 1998 Dec;20(4):467-76.

PMID:
9923956
45.

Eligibility criteria for NHS long stay care: the relationship between clinical need, dependency, and staff perception.

Scott SN, Gilchrist G, Hooke A, Roy CW.

Disabil Rehabil. 1998 May;20(5):179-88.

PMID:
9622263
46.

Non-Hodgkin's lymphoma of the middle ear cleft.

Scott SN, Burgess RC, Weber PC, Gantz BJ.

Otolaryngol Head Neck Surg. 1997 Dec;117(6):S203-5. No abstract available.

PMID:
9419149
47.

Strengths and limitations of using the Revised Elderly Person's Disability Scale (REPDS) as a research tool in a Scottish context.

Dallender J, Gilchrist G, Scott SN, Watt G.

Health Bull (Edinb). 1996 May;54(3):229-31. No abstract available.

PMID:
8707566
48.

SOUTH-WESTERN BRANCH: THE DOCTOR AND THE PUBLIC.

Scott SN.

Br Med J. 1910 Jul 16;2(2585):135-6. No abstract available.

Supplemental Content

Loading ...
Support Center